<DOC>
	<DOC>NCT02956720</DOC>
	<brief_summary>Prospective, open label, self - controlled, single arm, clinical study to assess the performance of the UltraShape Power using the U-Sculpt-N on outer thigh and/or flank for circumference reduction versus self-control.</brief_summary>
	<brief_title>UltraShape Power in Combination With U-sculpt-n Transducer</brief_title>
	<detailed_description />
	<criteria>1. Subject ≥25 and ≤60 years of age at the time of enrollment 2. BMI≤ 28 3. Fat thickness of at least 1.5 cm in the outer thigh and/or flank (measured by calibrated caliper) 4. For women of childbearing potential: negative urine pregnancy test 5. General good health confirmed by medical history and skin examination of the treated area 6. Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any studyspecific tests or procedures are performed. 7. The subject commits to return for the scheduled postoperative followup visits at the clinic Willingness to refrain from a change in diet/ exercise/medication regimen for the entire course of the study 1. History of unbalanced hypertension, ischemic heart disease, valvular heart disease, congestive heart failure, pacemaker/defibrillator 2. Current hyperlipidemia, diabetes mellitus, hepatitis, liver disease, HIV positive status, blood coagulopathy or excessive bleeding, autoimmune or connective tissue disease 3. Having a permanent implant in the treated area, such as metal plates, or an injected chemical substance such as silicone 4. Previous liposuction in the treatment areas within 12 months 5. History of skin disease in the treatment area, known tendency to form keloids or poor wound healing 6. Abnormal kidney, liver or coagulation functions, abnormal lipid profile or blood count within the last 3 months 7. Childbirth within the last 12 months or women who are breastfeeding a child 8. Any acute or chronic condition which, in the opinion of the Investigator, could interfere with the conduct of the study 9. Subjects with poor skin quality (i.e., laxity) and/or amorphic fat deposits at the target for treatment areas 10. Unstable weight within the last 6 months (i.e., more than ± 3% weight change in the prior 6 months) 11. Participation in another clinical study within the last 6 months 12. Previous body contouring treatments within the last 12months in the areas to be treated</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>